Meloxicam is an NSAID (oxicam) indicated for osteoarthritis and rheumatoid arthritis. We supply it to US manufacturers of tablets, capsules and oral suspension.
Data from PubChem (CID 54677470) and FDA’s substance registry
CAS number
71125-38-7
Molecular formula
C14H13N3O4S2
Molecular weight
351.4g/mol
FDA UNII
IUPAC name
4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide
InChIKey
ZRVUJXDFFKFLMG-UHFFFAOYSA-N
- Appearance
- Pale yellow powder.
- Solubility
- Practically insoluble in water, with higher solubility in strong acids and bases. Very slightly soluble in methanol.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Micronized material is typical for tablets and oral suspension.
On the US market
- Reference product
- MobicNDA 020938
- Approved ANDAs
- 15 with a marketed product
- Approved forms and strengths
- Tablet 7.5 mg, 15 mg
- Capsule 5 mg, 10 mg
- Oral suspension 7.5 mg/5 mL
- Injection 30 mg/mL
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com